With extensive expertise in the technology and healthcare sectors, the fund manager has successfully executed over 30 deals across North America and Asia. Their investment strategy leans towards early-stage companies, emphasizing a data-driven approach that prioritizes growth potential and scalability. A notable exit in the biotechnology space showcased their ability to identify and nurture high-value opportunities. This operator-first mentality enables them to leverage industry insights for effective portfolio management.